Insider Stock Trading History of Viret Jean-frederic


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Viret Jean-frederic since year 2005. The trader's CIK number is 1427569. At the time of this reporting, Viret Jean-frederic is the Chief Financial Officer of Coherus Biosciences, Inc. . (stock ticker symbol CHRS). See this page for all insider trading activities at Coherus Biosciences, Inc. .

Note that in the past Viret Jean-Frederic also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Viret Jean-frederic since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-25 CHRS Coherus Biosciences, Inc. Sale 3,900 27.00 105,300
2017-01-25 CHRS Coherus Biosciences, Inc. Option Ex 3,900 13.50 52,650
2016-12-16 CHRS Coherus Biosciences, Inc. Option Ex 3,900 13.50 52,650
2016-12-16 CHRS Coherus Biosciences, Inc. Sale 3,900 28.30 110,366
2016-12-19 CHRS Coherus Biosciences, Inc. Option Ex 667 13.50 9,004
2016-11-18 CHRS Coherus Biosciences, Inc. Option Ex 3,900 13.50 52,650
2016-11-18 CHRS Coherus Biosciences, Inc. Sale 3,900 28.19 109,956
2016-10-21 CHRS Coherus Biosciences, Inc. Sale 3,900 30.62 119,402
2016-10-21 CHRS Coherus Biosciences, Inc. Option Ex 3,900 13.50 52,650
2016-09-26 CHRS Coherus Biosciences, Inc. Option Ex 3,900 13.50 52,650
2016-09-26 CHRS Coherus Biosciences, Inc. Sale 3,900 29.89 116,551
2016-07-06 CHRS Coherus Biosciences, Inc. Option Ex 1,925 13.50 25,987
2016-03-28 CHRS Coherus Biosciences, Inc. Option Ex 400 13.50 5,400
2014-04-28 DDXS Vaxgen Inc Option Ex 2,108 .28 590
2013-03-27 DDXS Vaxgen Inc Option Ex 2,540 .28 711

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Viret Jean-frederic (Chief Financial Officer of Coherus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.